Further determination of the interaction between UBE2T and vimentin may not only provide more details to the function of UBE2T, but may also reveal a novel therapeutic target in PCa by disrupting the interaction between UBE2T and vimentin. This evidence concerns the gene VIM and posterior cortical atrophy.